dc.contributor.author | Nakanjako, Damalie | |
dc.contributor.author | Ssewanyana, Isaac | |
dc.contributor.author | Nabatanzi, Rose | |
dc.contributor.author | Kiragga, Agnes | |
dc.contributor.author | Kamya, Moses R. | |
dc.contributor.author | Cao, Huyen | |
dc.contributor.author | Mayanja-Kizza, Harriet | |
dc.date.accessioned | 2014-06-20T15:45:50Z | |
dc.date.available | 2014-06-20T15:45:50Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Nakanjako, D. et al. (2013). Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort. BMC Immunology,14:26 | en_US |
dc.identifier.other | doi:10.1186/1471-2172-14-26 | |
dc.identifier.uri | http://dx.doi.org/10.1186/1471-2172-14-26 | |
dc.identifier.uri | http://hdl.handle.net/10570/2939 | |
dc.description.abstract | Background: Most HIV-infected subjects exhibit a progressive rise in CD4 T-cell counts after initiation of highly active antiretroviral therapy (HAART). However, a subset of individuals exhibit very poor CD4 T-cell recovery despite effective control of HIV-RNA viraemia. We evaluated CD4 T-cell proliferation among suboptimal responders and its
correlation with CD4 T-cell activation.
Methods: The magnitude of CD4 increase (difference between absolute CD4 counts at baseline and absolute CD4 counts at 4 years of ART) was grouped into 4 quartiles for the 211 patients with sustained HIV-RNA viral suppression. Cases of ‘Suboptimal immune responders’ included patients within the lowest quartile [Median CD4
increase 165 (Range −43-298) cells/μl; n=52] and a comparison group of ‘Optimal immune responders’ was defined as patients within the highest quartile of CD4 increase [Median CD4 increase 528 (Range 417–878) cells/μl; n=52]. Frozen PBMC were thawed and analysed from a convenient sample of 39 suboptimal responders and 48 optimal responders after 4 years of suppressive antiretroviral therapy. T-cell activation was measured by proportions of T-cells expressing surface marker CD38 and HLADR (CD4+CD38+HLA-DR+ and CD8+CD38+HLA-DR+ cells). T-cell proliferation was determined by the extent of carboxyfluorescein diacetate succinimidyl ester (CFSE) dye dilution on culture day 5 of PBMCs in the presence of antigen (SEB, PPD, CMVpp65, GagA and GagD). Samples were analyzed on a FACS Calibur flow cytometer and flow data was analyzed using FlowJo and GraphPad.
Results: Overall, CD4 T-cell proliferation on stimulation with SEB, PPD, CMVpp65, Gag A and Gag D.antigens, was lower among suboptimal than optimal responders; this was significant for SEB (CD4+ p=0.003; CD8+ p=0.048) and PPD antigens (CD8+ p=0.038). Among suboptimal responders, T-cell proliferation decreased with increasing immune activation (Negative correlation; slope = −0.13±−0.11) but not among optimal responders.
Conclusion: T-cell immune activation and exhaustion were associated with poor proliferation among suboptimal responders to HAART despite sustained viral suppression. We recommend studies to further understand the mechanisms leading to impaired T-cell function among suboptimal responders as well as the potential role of
immune modulation in optimizing CD4 count and functional recovery after HAART. | en_US |
dc.description.sponsorship | Gilead AND Wellcome Trust. | en_US |
dc.language.iso | en | en_US |
dc.publisher | BMC Immunology | en_US |
dc.subject | T-cell proliferation | en_US |
dc.subject | Immune activation | en_US |
dc.subject | Suboptimal immune recovery | en_US |
dc.subject | HAART immune responses | en_US |
dc.subject | HIV/AIDS | en_US |
dc.title | Impaired T-cell proliferation among HAARTtreated adults with suboptimal CD4 recovery in an African cohort | en_US |
dc.type | Article | en_US |